Journal of Proteomics & Bioinformatics
Open Access
ISSN: 0974-276X
ISSN: 0974-276X
Ashok Amin
Professor, School of Biomedical Engineering and Sciences, ?Virginia Tech
Wake Forest University, USA
Dr. Ashok Amin obtained his PhD degree from MS University of Baroda, India in 1987 and completed his Post Doc from New York University, USA in 1991. He has an affiliation of Professorship in School of Biomedical Engineering, Virginia Tech, Wake Forest University, USA. He has also managed all translational research enhancements/management (pre and post grant/clinical trial), operations (research audits, IRB, risk management, legal) and compliance (CDC, HIPPA, NIH, EPA, NSF, DOD) from 2007 to 2009. He is the holder of many grants like National Institute of Health; New York Arthritis Foundation; National Arthritis Foundation; Hoffman-La Roche; Ciba-Geigy Pharm. Co.; Schering-Plough Pharm. Co.; Oxford GlycoSystems.; Collagenex Inc.; Park-Davis; DuPont-Merck Pharm. Co.; Yamanouchi Pharm. Co.; Forest Labs; Genomics Collaborative; Ranbaxy Laboratories; Gene Logic Inc.; Merckle GmbH; and Merck; and internal institutional grants. So far Dr. Amin has published more than 90 papers in International publication and many more are on pipeline.
Dr. Ashok Amin obtained his PhD degree from MS University of Baroda, India in 1987 and completed his Post Doc from New York University, USA in 1991. He has an affiliation of Professorship in School of Biomedical Engineering, Virginia Tech, Wake Forest University, USA. He has also managed all translational research enhancements/management (pre and post grant/clinical trial), operations (research audits, IRB, risk management, legal) and compliance (CDC, HIPPA, NIH, EPA, NSF, DOD) from 2007 to 2009. He is the holder of many grants like National Institute of Health; New York Arthritis Foundation; National Arthritis Foundation; Hoffman-La Roche; Ciba-Geigy Pharm. Co.; Schering-Plough Pharm. Co.; Oxford GlycoSystems.; Collagenex Inc.; Park-Davis; DuPont-Merck Pharm. Co.; Yamanouchi Pharm. Co.; Forest Labs; Genomics Collaborative; Ranbaxy Laboratories; Gene Logic Inc.; Merckle GmbH; and Merck; and internal institutional grants. So far Dr. Amin has published more than 90 papers in International publication and many more are on pipeline.